Beta Bionics Inc

NEW
NAS:BBNX (USA)  
$ 11.06 +0.59 (+5.64%) 11:08 PM EST
At Loss
Market Cap:
$ 479.44M
Enterprise V:
$ 357.54M
Volume:
272.91K
Avg Vol (2M):
537.28K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
272.91K
At Loss
Avg Vol (2M):
537.28K

Business Description

Beta Bionics Inc
NAICS : 339112 SIC : 5047
ISIN : US08659B1026
Description
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
Name Current Vs Industry Vs History
Cash-To-Debt 14.28
Equity-to-Asset -1.64
Debt-to-Equity -0.03
Debt-to-EBITDA -0.9
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.93
Distress
Grey
Safe
Beneish M-Score 7.93
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 57.95
9-Day RSI 47.96
14-Day RSI 42.59

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.29
Quick Ratio 5.66
Cash Ratio 4.9
Days Inventory 359.48
Days Sales Outstanding 142.31
Days Payable 95.46

Dividend & Buy Back

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 23.19
EV-to-EBIT -41.55
EV-to-EBITDA -44.27
EV-to-Revenue 17.49
EV-to-FCF -53.68
Earnings Yield (Greenblatt) % -2.41
FCF Yield % -1.39

Financials (Next Earnings Date:2025-05-06)

BBNX's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BBNX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Beta Bionics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 20.44
EPS (TTM) ($) -0.422
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % -
14-Day RSI 42.59
14-Day ATR ($) 1.213882
20-Day SMA ($) 10.957
12-1 Month Momentum % -
52-Week Range ($) 8.89 - 24.5
Shares Outstanding (Mil) 43.35

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Beta Bionics Inc Filings

Filing Date Document Date Form
No Filing Data

Beta Bionics Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Beta Bionics Inc Frequently Asked Questions

What is Beta Bionics Inc(BBNX)'s stock price today?
The current price of BBNX is $11.06. The 52 week high of BBNX is $24.50 and 52 week low is $8.89.
When is next earnings date of Beta Bionics Inc(BBNX)?
The next earnings date of Beta Bionics Inc(BBNX) is 2025-05-06.
Does Beta Bionics Inc(BBNX) pay dividends? If so, how much?
Beta Bionics Inc(BBNX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1